Skye Bioscience, Inc. (SKYE) vs Traws Pharma, Inc. (TRAW)

Skye Bioscience, Inc. and Traws Pharma, Inc. are both Biotechnology companies. Skye Bioscience, Inc. and Traws Pharma, Inc. are of similar size ($7.5M and $7.3M). Across the 10 metrics below, Traws Pharma, Inc. leads on 8 and Skye Bioscience, Inc. on 2.

Valuation

Metric SKYE TRAW Biotechnology median
P/E n/m n/m 7.88
P/S 27.76 3.12 11.47
P/B n/m 5.25 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 14.91 1.36 10.73
Earnings yield (608.38%) (314.29%) (28.84%)
Free cash flow yield (461.87%) (189.82%) (23.03%)

Profitability

Metric SKYE TRAW Biotechnology median
Gross margin 68.04% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (233.87%) (319.42%) (57.72%)
Return on assets (159.80%) (117.35%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric SKYE TRAW Biotechnology median
Revenue growth (TTM) — 1,159.29% 5.64%
EPS growth (last fiscal year) (93.15%) 100.76% —
Revenue growth, 5-year CAGR — 64.59% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SKYE TRAW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.95 0.93 4.73
Net debt to EBITDA 0.45 0.21 0.96

Dividend

Metric SKYE TRAW Biotechnology median
Dividend yield — — 2.10%
Payout ratio — 0.00 0.00

Size

Metric SKYE TRAW Biotechnology median
Market cap 7.53m 7.26m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack